VCM
BSX icon

Vigilant Capital Management’s Boston Scientific BSX Stock Holding History

Vigilant Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-36
Closed -$1K – 507
2022
Q3 		$1K Buy
+36
New +$1.44K ﹤0.01% 558
2021
Q4 		– Sell
-179
Closed -$8K – 640
2021
Q3 		$8K Buy
+179
New +$7.92K ﹤0.01% 531

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Vigilant Capital Management's BSX Position: Q4 2022 in Review

Vigilant Capital Management sold out of Boston Scientific (BSX) in Q4 2022, closing a stake of 36 shares — an estimated $1K sold.

Vigilant Capital Management first reported a position in BSX in Q3 2021 and held it in 2 quarters. The position peaked at $8K in Q3 2021. 928 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • Vigilant Capital Management reported no remaining Boston Scientific position as of Q4 2022 after selling out during the quarter.
  • Vigilant Capital Management sold 36 Boston Scientific shares in Q4 2022, an estimated $1K.
  • Vigilant Capital Management first reported a position in Boston Scientific in Q3 2021 and held it in 2 quarters.
  • Vigilant Capital Management's Boston Scientific position peaked at $8K in Q3 2021.
  • 928 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Vigilant Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.